Company news
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) news
Rapid Micro Biosystems, Inc. news releases on 6ix. Latest, Aug 7, 2026: Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
Press releases & updates
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
August 7, 2026
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 4, 2026
August 5, 2026
Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026
July 23, 2026
Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2026
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
May 17, 2026
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
May 12, 2026
Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026
May 6, 2026
Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform
March 11, 2026
Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum
March 10, 2026
Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference
February 26, 2026
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
February 24, 2026
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 12, 2026
Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
January 13, 2026
Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
November 7, 2025
Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference
October 30, 2025
Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025
October 28, 2025
Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices
September 22, 2025
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025
Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
August 12, 2025
Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
August 12, 2025
Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025
July 31, 2025
Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
May 27, 2025
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
May 9, 2025
Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025
April 24, 2025
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
February 28, 2025
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany
February 27, 2025
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
February 26, 2025
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025
February 20, 2025
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
January 13, 2025
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
October 31, 2024
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results
August 1, 2024
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
May 2, 2024
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
April 17, 2024
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
February 29, 2024
Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System
January 9, 2024
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue
January 9, 2024
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
November 2, 2023
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
October 18, 2023
Rapid Micro Biosystems Reports Second Quarter 2023 Financial Results
August 3, 2023
Rapid Micro Biosystems to Announce Second Quarter 2023 Financial Results on August 4, 2023
July 19, 2023
Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors
July 17, 2023
Rapid Micro Biosystems Reports First Quarter 2023 Financial Results
May 4, 2023
Rapid Micro Biosystems Announces the Appointment of Michael Wysocki as Senior Vice President, Sales and Marketing
May 3, 2023
Rapid Micro Biosystems to Announce First Quarter 2023 Financial Results on May 5, 2023
April 12, 2023
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance
March 2, 2023
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue
January 10, 2023
Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology
December 6, 2022
Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results
November 9, 2022
Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System
October 9, 2022